[Research Report] The pharmacovigilance and drug safety software market is expected to reach US$ 292.97 Mn in 2027 from US$ 160.67 Mn in 2019. The market is estimated to grow with a CAGR of 7.6% from 2020-2027.
The scope of the pharmacovigilance and drug safety software market includes software type, product type, end user, and region. The market for pharmacovigilance and drug safety software, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America.The report offers insights and in-depth analysis of the Pharmacovigilance and Drug Safety Software market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across all the regions.
Lucrative Regions for Pharmacovigilance and Drug Safety Software Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Globalization Of Pharmacovigilance
Pharmacovigilance is the processes for monitoring and evaluating adverse drug reactions and it is a key component of effective drug regulation systems, clinical practice and public health programs. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled. In the current global network of pharmacovigilance centers coordinated by the Uppsala Monitoring Centre. Pharmacovigilance is an critical and integral part of clinical research and these days it is growing in many countries. Today many pharmacovigilance centers are working for drug safety monitoring in this global pitch, however, at the turn of the millennium pharmacovigilance faces major challenges in aspect of better safety and monitoring of drugs.
The centralized reporting and storage of adverse drug reaction reports will help to monitor and prevent future adverse drug reaction from the drug. European Medicines Agency (EMA) and US Food and Drug Administration (FDA) strengthening in pharmacovigilance area by interacting on different topics related to post-marketing safety, scientific exchange. Discussions on priority such as biosimilars, medicines to treat cancer, orphan medicines, medicines for children, and blood-based products, among other topics.
Thus, increasing the globalization in pharmacovigilance sector helps in drug safety software. It improves the quality and efficacy of pharmacovigilance and drug safety software and is expected to favor the growth of the market during the forecast period.
Software Type-Based Insights
Based on software type the market is segmented into adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. In 2019, the adverse event reporting software segment held the largest share of the market, by software. However, the fully integrated software segment is anticipated to grow at the highest rate during the forecast period owing to its accuracy to avoid data redundancy by eliminating errors and tracking individual case safety reports.
Global Pharmacovigilance and Drug Safety Software Market, by Software Type – 2019 & 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Delivery Mode -Based Insights
Based on delivery mode the market is segmented into on premise and cloud based. In 2019, the on-premise segment held the largest share of the market, by delivery mode. However, Cloud based segment is expected to grow at the fastest rate during the coming years owing to the benefits associated such as remote access to data, real-time data tracking.
End User-Based Insights
Based on end user the market is segmented into pharmaceutical and biotech companies, contract research organizations (CROs) and business process outsourcing (BPO) Firms. In 2019, the contract research organizations segment held the largest share of the market, by end user. Moreover, Contract Research Organizations segment is expected to grow at the fastest rate during the coming years owing to increasing drug discovery activities in the pharmaceutical companies.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmacovigilance and Drug Safety Software Market: Strategic Insights
Market Size Value in US$ 160.67 Million in 2019 Market Size Value by US$ 292.97 Million by 2027 Growth rate CAGR of 7.6% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmacovigilance and Drug Safety Software Market: Strategic Insights
| Market Size Value in | US$ 160.67 Million in 2019 |
| Market Size Value by | US$ 292.97 Million by 2027 |
| Growth rate | CAGR of 7.6% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater to changing customer demand and maintain their brand name across the world. Market players operating in the pharmacovigilance and drug safety software market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.
By Software Type
- Fully Integrated Software
- Adverse Event Reporting Software
- Drug Safety Audits Software
- Issue Tracking Software
By Delivery Mode
- Cloud-based
- On-premise
By End User
- Contract Research Organizations
- Pharmaceutical and Biotech Companies
- Business Process Outsourcing
By
Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Veeva Systems
- IQVIA Inc.
- Ennov
- AB Cube
- United Biosource LLC
- ArisGlobal LLC
- Sparta Systems
- Oracle Corporation
- Sarjen Systems Pvt. Ltd
- EXTEDO
- Maxapplication
- Online Business Applications, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Software Type ; Delivery Mode ; and End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Pharmacovigilance (PV) plays an important role in drug monitoring and identification of drug interactions with human. The fully integrated software segment are expected to contribute in the growth of pharmacovigilance and drug safety market.
Rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have been boosting the market over the years. However, the expensive technology are likely to have a negative impact on the growth of the market in the coming years.
The costs of the pharmacovigilance and drug safety software are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product and software types.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Software Type
1.3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Delivery Mode
1.3.3 Global Pharmacovigilance (PV) and Drug Safety Software Market – By End User
1.3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Geography
2. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Pharmacovigilance (PV) and Drug Safety Software Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
5. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences Of Adverse Drug Reactions (ADRs)
5.1.2 Globalization Of Pharmacovigilance
5.2 Key Market Restraints
5.2.1 Expensive Technology
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence In Pharmacovigilance
5.5 Impact Analysis
6. Pharmacovigilance (PV) and Drug Safety Software Market – Global Analysis
6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis
6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis– by Software Type
7.1 Overview
7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2019 & 2027 (%)
7.3 Adverse Event Reporting Software Market
7.3.1 Overview
7.3.2 Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Drug Safety Audits Software
7.4.1 Overview
7.4.2 Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Issue Tracking Software
7.5.1 Overview
7.5.2 Global Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Fully Integrated Software
7.6.1 Overview
7.6.2 Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by Delivery Mode
8.1 Overview
8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)
8.3 On-premise Market
8.3.1 Overview
8.3.2 Global On-premise Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cloud- Based Market
8.4.1 Overview
8.4.2 Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)
9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by End User
9.1 Overview
9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User 2019 & 2027 (%)
9.3 Pharmaceutical and Biotech Companies Market
9.3.1 Overview
9.3.2 Global Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Contract Research Organizations (CROs) Market
9.4.1.1 Overview
9.4.1.2 Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Business Process Outsourcing (BPO) Firms Market
9.5.1 Overview
9.5.2 Global Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)
10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.1.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.1.4 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.5 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.6.1 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.6.2 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.7 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.8.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.8.2 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.9 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.10.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.10.2 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.2.4 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.5 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.6.1 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.6.2 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.7 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.8.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.8.2 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.8.3 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.10.1 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.10.2 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.11 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.12 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.12.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.12.2 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.13 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.14 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.15.1 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.15.2 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.16 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.18 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.18.1 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.18.2 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.3.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.2.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.2.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.3.4 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.5 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.6 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.6.1 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.6.2 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.6.3 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.8.1 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.8.2 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.9 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.11.1 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.11.2 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.12 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.13 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.14.1 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.14.2 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.15 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.17 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.17.1 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.17.2 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.18 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.19 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.20 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.20.1 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.20.2 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.4.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.2.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.2.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.4.4 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.5 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.6 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.6.1 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.6.2 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.7 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.8.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.8.2 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.9 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.10 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.11.1 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.11.2 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.12 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.13 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.14 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.14.1 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.14.2 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5 South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.5.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.2.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.2.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5.3 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.5.4 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.5 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.6 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.6.1 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.6.2 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5.7 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.9 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.9.1 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.9.2 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5.10 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.11 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.12 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.12.1 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.12.2 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
11. Pharmacovigilance (PV) and Drug Safety Software Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done by Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Growth Strategies by Companies
12. Pharmacovigilance (PV) and Drug Safety Software Market–Key Company Profiles
12.1 Veeva Systems
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 IQVIA Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ennov
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AB Cube
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 United Biosource LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ArisGlobal LLC
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sparta Systems
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Oracle Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Sarjen Systems Pvt. Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 EXTEDO
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Maxapplication
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Online Business Applications, Inc.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
LIST OF TABLES
Table 1. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 2. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 3. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 4. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 5. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 6. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 7. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 8. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 9. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 10. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 11. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 12. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 13. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 14. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 15. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 16. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 17. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 18. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 19. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 20. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 21. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 22. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 23. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 24. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 25. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 26. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 27. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 28. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 29. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 30. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 31. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 32. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 33. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 34. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 35. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 36. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 37. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 38. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 39. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 40. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 41. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 42. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 43. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 44. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 45. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 46. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 47. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 48. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 49. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 50. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 51. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 52. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 53. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 54. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 55. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 57. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 58. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 59. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 60. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 61. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 62. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 63. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 64. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 65. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 66. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 67. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 68. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 69. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 70. Recent Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
Table 71. Recent Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
Table 72. Glossary of Terms, Pharmacovigilance (PV) and Drug Safety Software Market
LIST OF FIGURES
Figure 1. Pharmacovigilance (PV) and Drug Safety Software Market Segmentation
Figure 2. Pharmacovigilance (PV) and Drug Safety Software Market Segmentation, by Region
Figure 3. Global Pharmacovigilance (PV) and Drug Safety Software Market Overview
Figure 4. Adverse Event Reporting Software Segment Held Largest Share Of The Software Type Segment In Pharmacovigilance (PV) and Drug Safety Software Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography (US$ Mn)
Figure 7. Global Pharmacovigilance (PV) and Drug Safety Software Market- Leading Country Markets (US$ Mn)
Figure 8. Global Pharmacovigilance (PV) and Drug Safety Software Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Driver and Restraints Pertaining to Pharmacovigilance (PV) and Drug Safety Software Market
Figure 15. Global Pharmacovigilance (PV) and Drug Safety Software Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 16. Global Pharmacovigilance (PV) and Drug Safety Software Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 17. Prominent Players in the Pharmacovigilance (PV) and Drug Safety Software Market
Figure 18. Global Pharmacovigilance (PV) and Drug Safety Software Market, by Product & Services 2019 & 2027 (%)
Figure 19. Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)
Figure 24. Global Chemical Compounds Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Pharmacovigilance (PV) and Drug Safety Software Market, by End User 2019 & 2027 (%)
Figure 27. Global Pharmaceutical And Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 31. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 33. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 35. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 37. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 39. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 45. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 47. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 53. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 55. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 59. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 61. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 62. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019
The List of Companies - Pharmacovigilance and Drug Safety Software Market
- Veeva Systems
- IQVIA Inc.
- Ennov
- AB Cube
- United Biosource LLC
- ArisGlobal LLC
- Sparta Systems
- Oracle Corporation
- Sarjen Systems Pvt. Ltd
- EXTEDO
- Maxapplication
- Online Business Applications, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pharmacovigilance and Drug Safety Software Market
Jan 2021
Emergency Call Systems Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Fall Prevention and Detection, Workflow Optimization, Patient Care Reminders, Alarms and Communication Management, Wander Management, Reporting and Analytics, Real-Time Staff Locating, and Others), End User (Hospital and Clinics, Assisted Living and Independent Living Facilities, Ambulatory Surgical Centers, and Others), Technology (Wired and Wireless), Offering (Hardware, Software, and Services), Product Type (Nurse Call Systems, Call Box Systems, Emergency Stanchions, Intercom System, and Others),, and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Outpatient Central Fulfillment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labeling Systems, Automated Tabletop Counters, Automated Storage and Retrieval Systems, and Others), End User (Hospital Pharmacies, Retail Pharmacies, and Mail-Order Pharmacies), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2021
Well-Being Platform Market
Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
Jan 2021
Product Design and Development Services Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Services (Research, Strategy, and Concept Generation; Concept and Requirement Development; Detailed Design and Process Development; Process Validation, Manufacturing Transfer, and Design Validation; and Other Services), Application (Diagnostic Equipment, Therapeutic Equipment, Surgical Instruments, Clinical Laboratory Equipment, Biological Storage, Consumables, and Others), and End User (Medical Companies, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations)
Jan 2021
Patient Engagement Technology Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Services, Hardware, and Software), Therapeutic Area (Fitness, Chronic Diseases, Women’s Health, and others), Delivery Mode (Cloud-Based and On-Premises), Application (Health Management, Financial Health Management, Home Healthcare Management, and Others), and End User (Patients, Payers, Providers, and Others)
Jan 2021
IVD Contract Research Organization Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
Jan 2021
Dental CAD/CAM Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Dental CAD/CAM Materials (Glass Ceramics, Alumina-Based Ceramics, Lithium Disilicate, Zirconia, and Others) and Dental CAD/CAM Systems], Type (In-Office Systems and In-Lab Systems), Components [Hardware (Dental Printers, Milling Machines, Scanners, and Others) and Software], Application (Dental Prosthesis, Dental Implants, and Others), and End User (Dental Clinics, Dental Laboratories, Milling Centers, and Others)
Jan 2021
Emergency Medical Software Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Early Warning and Vulnerability Alert System (EWVAS), EMS Computer Aided Dispatch (CAD) System, Incident Response Software, Ambulance Management Software, and Others], Mode of Delivery [On Premises and Software as a Service (SaaS)], Platform (Android, iOS, Windows, and Others), and End User (Commercial, Municipal, State City Agencies, and Others)